Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / EAF - Bragar Eagel & Squire P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AlloVir GrafTech Instacart and Boeing and Encourages Investors to Contact the Firm | Benzinga


EAF - Bragar Eagel & Squire P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AlloVir GrafTech Instacart and Boeing and Encourages Investors to Contact the Firm | Benzinga

  • NEW YORK, Feb. 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of AlloVir, Inc. (NASDAQ:ALVR), GrafTech International Ltd. (NYSE:EAF), Maplebear, Inc. d/b/a Instacart (NASDAQ:CART), and The Boeing Company (NYSE:BA). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

    AlloVir, Inc. (NASDAQ:ALVR)

    Class Period: March 22, 2022 - December 21, 2023

    Lead Plaintiff Deadline: March 19, 2024

    The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the posoleucel Phase 3 Studies were unlikely to meet their primary endpoints; (ii) as a result, it was likely that the Company would ultimately discontinue the posoleucel Phase 3 studies; (iii) accordingly, AlloVir overstated the efficacy and clinical and/or commercial prospects of posoleucel; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

    On December 22, 2023, AlloVir announced that it was discontinuing the posoleucel Phase 3 studies over efficacy concerns and stated that it would explore strategic alternatives for the Company. Specifically, AlloVir said it was discontinuing the posoleucel Phase 3 studies after pre-planned analyses concluded they wouldn't meet their primary endpoints.

    On this news, AlloVir's stock price fell $1.57 per share, or 67.38%, to close at $0.76 per share on December 22, 2023.

    For more information on the AlloVir class action go to: https://bespc.com/cases/ALVR

    GrafTech International Ltd. (NYSE:EAF)

    Class Period: February 8, 2019 - August 3, 2023 (Common Stock Only)

    Lead Plaintiff Deadline: March 25, 2024

    The GrafTech class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) GrafTech's manufacturing operations in Monterrey, Mexico had for decades chronically contaminated neighboring communities with harmful carcinogenic gasses and particulate matter; (ii) GrafTech had signed agreements with local authorities committing itself to improving the environmental performance of its Monterrey facility, but repeatedly failed to honor these commitments; (iii) GrafTech had been repeatedly warned over an approximately 30-year period regarding its wanton disregard for the environment and health and well-being of people near its operations in Monterrey, Mexico; (iv) GrafTech's operations in Monterrey, Mexico were not in compliance with applicable environmental laws and regulations; (v) GrafTech had failed to adequately remediate the environmental problems caused by the Monterrey facility following the 2019 administrative proceeding conducted by the Department of Sustainable Development of the State of Nuevo León; (vi) the government of Apodaca had sought intervention from the State of Nuevo León authorities to curtail and prevent the adverse environmental impacts and noncompliance with environmental laws and regulations caused by the Monterrey facility; (vii) GrafTech's purported cost leadership was achieved in substantial part by failing to implement appropriate and effective environmental safeguards at its manufacturing facility in Monterrey, Mexico; (viii) GrafTech's capital expenditures and/or related operational projects were woefully insufficient to adequately address the harm that GrafTech's operations in Monterrey, Mexico had ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: GrafTech International Ltd.
    Stock Symbol: EAF
    Market: NYSE
    Website: graftech.com

    Menu

    EAF EAF Quote EAF Short EAF News EAF Articles EAF Message Board
    Get EAF Alerts

    News, Short Squeeze, Breakout and More Instantly...